|
Nov 5
|
Kura Oncology, Inc. (NASDAQ:KURA) Q3 2023 Earnings Call Transcript
|
|
Nov 2
|
Kura Oncology Inc (KURA) Reports Q3 2023 Financial Results
|
|
Nov 2
|
Kura Oncology Reports Third Quarter 2023 Financial Results
|
|
Nov 2
|
Kura Oncology and Mirati Therapeutics Enter into Clinical Collaboration and Supply Agreement to Evaluate KO-2806 and Adagrasib in KRASᴳ¹²ᶜ-Mutated NSCLC
|